Vaccine company
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2025 | VALNEVA USA, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination |
$120,000 | |
| 2025 | VALNEVA USA, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$120,000 | |
| 2025 | VALNEVA USA, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$110,000 | |
| 2025 | VALNEVA USA, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$130,000 | |
| 2024 | VALNEVA USA, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$140,000 | |
| 2024 | VALNEVA USA, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$140,000 | |
| 2024 | VALNEVA USA, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$190,000 | |
| 2024 | VALNEVA USA, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$130,000 | |
| 2023 | VALNEVA USA, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$220,000 | |
| 2023 | VALNEVA USA, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$220,000 |
| Firm | Filings | Expenses |
|---|---|---|
| VALNEVA USA, INC. | 17 | $2,480,000 |
| Issue | Activities |
|---|---|
| Health Issues | 17 |
| Science/Technology | 1 |
| Pharmacy | 1 |
| Travel/Tourism | 1 |